Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v3.24.2.u1
Concentrations
6 Months Ended
Jun. 30, 2024
Risks and Uncertainties [Abstract]  
Concentrations

NOTE 12—CONCENTRATIONS

Revenue from the Company’s products are as follows (dollars in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Laser systems

 

$

6,007

 

 

 

52.0

%

 

$

8,754

 

 

 

61.3

%

 

$

11,182

 

 

 

51.6

%

 

$

15,019

 

 

 

60.7

%

Consumables and other

 

 

3,835

 

 

 

33.2

%

 

 

4,117

 

 

 

28.8

%

 

 

7,304

 

 

 

33.6

%

 

 

7,150

 

 

 

28.9

%

Services

 

 

1,713

 

 

 

14.8

%

 

 

1,415

 

 

 

9.9

%

 

 

3,201

 

 

 

14.8

%

 

 

2,584

 

 

 

10.4

%

Net revenue

 

$

11,555

 

 

 

100.0

%

 

$

14,286

 

 

 

100.0

%

 

$

21,687

 

 

 

100.0

%

 

$

24,753

 

 

 

100.0

%

 

No individual customer represented more than 10% of the Company’s revenue for the three and six months ended June 30, 2024 or 2023.

The Company maintains its cash and cash equivalents in money market investment accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

As of June 30, 2024, accounts receivable from one customer totaled approximately 12% of total gross accounts receivable with the entire balance being current. As of December 31, 2023 accounts receivable from one customer totaled approximately 11% of total gross accounts receivable which has been partially received in 2024 and partially reserved for uncollectibility as of June 30, 2024.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s business, results of operations and financial condition.